This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07495/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07495/identifier/pubchem-compound/
n10http://bio2rdf.org/drugbank:
n14http://linked.opendata.cz/resource/drugbank/drug/DB07495/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n4http://linked.opendata.cz/resource/drugbank/drug/DB07495/identifier/drugbank/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07495/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07495
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n10:DB07495 n12:DB07495
dcterms:title
5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE
adms:identifier
n4:DB07495 n7:BSM n8:20120287 n13:5327095 n14:99443966
n5:IUPAC-Name
n6:271B49EF-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B49F5-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B49F4-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B49F1-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B49F2-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B49F3-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B49ED-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B49EB-363D-11E5-9242-09173F13E4C5 n6:271B49EE-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B49EC-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B49FB-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B49FC-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B49F6-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B49F7-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B49F9-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B49F8-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B49FA-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4A01-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4A03-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4A04-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4A00-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B49FF-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4A02-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B49F0-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B49FD-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B49FE-363D-11E5-9242-09173F13E4C5